Emerging World Pharma, Inc.
For Immediate Release Investor Alert OSC
20 Queen St. W.
Box 55, Suite 1900
Toronto, ON M5H 3S8
|FOR IMMEDIATE RELEASE
December 12, 2012
TORONTO – The Ontario Securities Commission (OSC) is warning Ontario investors to exercise caution in any dealings with representatives of Emerging World Pharma, Inc. (“Emerging World”).
While Emerging World represents itself to be headquartered in Sunyani, Ghana, its officers and director are residents of Ontario and its shares were traded on the over-the-counter market in the United States.
On December 6, 2012, the U.S. Securities and Exchange Commission (SEC) suspended trading in the shares of Emerging World , noting that “questions have arisen concerning the adequacy and accuracy of press releases and other public statements concerning Emerging World’s business operation and financial condition.”
Trading in the shares of Emerging World has been suspended for a period of 10 days, ending at 11:59 p.m. EST on December 19, 2012.
The mandate of the OSC is to provide protection to investors from unfair, improper or fraudulent practices and to foster fair and efficient capital markets and confidence in capital markets. Investors are urged to check the registration of any person or company offering an investment opportunity and to review the OSC’s investor materials available at www.osc.gov.on.ca
If you have any questions or information relating to this matter, please contact the OSC Contact Centre at 1-877-785-1555.
|For Media Inquiries: [email protected]||Carolyn Shaw-Rimmington
Manager, Public Affairs
Media Relations Specialist
|Follow us on Twitter:||OSC_News
|For Investor Inquiries:||OSC Contact Centre
1-877-785-1555 (Toll Free)